Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1450 (-2.39%) ($7.1450 - $7.1450) on Wed. Jun. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 30 | Latest Price | $7.1450(-2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(26%) EWI(26%) EWJ(24%) SDY(24%) XLRE(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.445% in a week (0% probabilities). VIXM(-27%) VXX(-22%) SHY(-19%) VCIT(-18%) TLT(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.75(-138.49%) | Resistance Level | $8.15 | 5 Day Moving Average | $7.56(-5.49%) | 10 Day Moving Average | $8.01(-10.8%) | 20 Day Moving Average | $8.15(-12.33%) | To recent high | -19.3% | To recent low | 0% | Market Cap | $1.261b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |